-
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
-
Germline Genetic Testing Lags Behind Guidelines
Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
-
Increasing Diversity in Clinical Trials
Researchers share approaches for improving participation among underrepresented groups at AACR conference.
by Thomas Celona
-
Fixing Systems, Building Trust
The AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved explores efforts needed to address inequities in care and outcomes.
by Eric Fitzsimmons
-
From the Editor-in-Chief
Immunotherapy Gets Personal
Therapeutic vaccines can stimulate an immune response to cancer.
by William G. Nelson, MD, PhD
-
Forward Look
The Promise of Liquid Biopsies
Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.
by Tara Haelle
-
Forward Look
Should Race Inform Screening Recommendations?
Study suggests incorporating race and ethnicity in age-based breast cancer screening guidelines.
by Darcy Lewis
-
Forward Look
Diaphragm Disturbances
Hiccups are a common and underreported side effect of some cancer treatments.
by Carolyn Bernhardt
-
Immunotherapy: When Is Sooner Better Than Later?
Researchers explore whether giving immunotherapy before surgery and other treatments could improve outcomes for people with cancer.
by Stephen Ornes
-
Living With Chronic Blood Cancer
Thanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.
by Kendall K. Morgan
Cancer Talk
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
Germline Genetic Testing Lags Behind GuidelinesLow rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
Progress in Lung CancerNovember is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.
Against All OddsAt age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.
by Karon Warren